FTC’s Salvos Against Biopharma To Reverberate Through 2024

 
• By Brenda Sandburg
  
FTC building
Federal Trade Commission took aggressive actions against the biopharma industry last year • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Access

More from In Vivo